227 related articles for article (PubMed ID: 36582533)
1. Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response.
Zhao Z; Feng L; Peng X; Ma T; Tong R; Zhong L
Front Pharmacol; 2022; 13():1073713. PubMed ID: 36582533
[TBL] [Abstract][Full Text] [Related]
2. SETDB1: Progress and prospects in cancer treatment potential and inhibitor research.
Ma T; Xu F; Hou Y; Shu Y; Zhao Z; Zhang Y; Bai L; Feng L; Zhong L
Bioorg Chem; 2024 Apr; 145():107219. PubMed ID: 38377821
[TBL] [Abstract][Full Text] [Related]
3. The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease.
Luo H; Wu X; Zhu XH; Yi X; Du D; Jiang DS
Epigenetics Chromatin; 2023 Dec; 16(1):47. PubMed ID: 38057834
[TBL] [Abstract][Full Text] [Related]
4. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer.
Prashanth S; Radha Maniswami R; Rajajeyabalachandran G; Jegatheesan SK
Drug Discov Today; 2024 May; 29(5):103982. PubMed ID: 38614159
[TBL] [Abstract][Full Text] [Related]
5. SETDB1: A perspective into immune cell function and cancer immunotherapy.
Johnson E; Salari K; Yang S
Immunology; 2023 May; 169(1):3-12. PubMed ID: 36524435
[TBL] [Abstract][Full Text] [Related]
6. The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma.
Yuan L; Sun B; Xu L; Chen L; Ou W
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299035
[TBL] [Abstract][Full Text] [Related]
7. SETDB1-Mediated Silencing of Retroelements.
Fukuda K; Shinkai Y
Viruses; 2020 May; 12(6):. PubMed ID: 32486217
[TBL] [Abstract][Full Text] [Related]
8. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Griffin GK; Wu J; Iracheta-Vellve A; Patti JC; Hsu J; Davis T; Dele-Oni D; Du PP; Halawi AG; Ishizuka JJ; Kim SY; Klaeger S; Knudsen NH; Miller BC; Nguyen TH; Olander KE; Papanastasiou M; Rachimi S; Robitschek EJ; Schneider EM; Yeary MD; Zimmer MD; Jaffe JD; Carr SA; Doench JG; Haining WN; Yates KB; Manguso RT; Bernstein BE
Nature; 2021 Jul; 595(7866):309-314. PubMed ID: 33953401
[TBL] [Abstract][Full Text] [Related]
10. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.
Zhang SM; Cai WL; Liu X; Thakral D; Luo J; Chan LH; McGeary MK; Song E; Blenman KRM; Micevic G; Jessel S; Zhang Y; Yin M; Booth CJ; Jilaveanu LB; Damsky W; Sznol M; Kluger HM; Iwasaki A; Bosenberg MW; Yan Q
Nature; 2021 Oct; 598(7882):682-687. PubMed ID: 34671158
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination-dependent and -independent repression of target genes by SETDB1 reveal a context-dependent role for its methyltransferase activity during adipogenesis.
Zhang J; Matsumura Y; Kano Y; Yoshida A; Kawamura T; Hirakawa H; Inagaki T; Tanaka T; Kimura H; Yanagi S; Fukami K; Doi T; Osborne TF; Kodama T; Aburatani H; Sakai J
Genes Cells; 2021 Jul; 26(7):513-529. PubMed ID: 33971063
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.
Torrano J; Al Emran A; Hammerlindl H; Schaider H
Clin Epigenetics; 2019 Mar; 11(1):43. PubMed ID: 30850015
[TBL] [Abstract][Full Text] [Related]
14. The Histone Methyltransferase SETDB1 Controls T Helper Cell Lineage Integrity by Repressing Endogenous Retroviruses.
Adoue V; Binet B; Malbec A; Fourquet J; Romagnoli P; van Meerwijk JPM; Amigorena S; Joffre OP
Immunity; 2019 Mar; 50(3):629-644.e8. PubMed ID: 30737147
[TBL] [Abstract][Full Text] [Related]
15. Histone methyltransferase SETDB1 maintains survival of mouse spermatogonial stem/progenitor cells via PTEN/AKT/FOXO1 pathway.
Liu T; Chen X; Li T; Li X; Lyu Y; Fan X; Zhang P; Zeng W
Biochim Biophys Acta Gene Regul Mech; 2017 Oct; 1860(10):1094-1102. PubMed ID: 28890329
[TBL] [Abstract][Full Text] [Related]
16. Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation.
Singh SK; Bahal R; Rasmussen TP
Exp Cell Res; 2020 Oct; 395(2):112216. PubMed ID: 32768498
[TBL] [Abstract][Full Text] [Related]
17. A regulatory circuitry comprising TP53,
Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
[TBL] [Abstract][Full Text] [Related]
18. Histone-lysine N-methyltransferase SETDB1 is required for development of the bovine blastocyst.
Golding MC; Snyder M; Williamson GL; Veazey KJ; Peoples M; Pryor JH; Westhusin ME; Long CR
Theriogenology; 2015 Nov; 84(8):1411-22. PubMed ID: 26279314
[TBL] [Abstract][Full Text] [Related]
19. Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
Strepkos D; Markouli M; Klonou A; Papavassiliou AG; Piperi C
Cancer Res; 2021 Feb; 81(3):525-534. PubMed ID: 33115801
[TBL] [Abstract][Full Text] [Related]
20. The H3K9 Methylation Writer SETDB1 and its Reader MPP8 Cooperate to Silence Satellite DNA Repeats in Mouse Embryonic Stem Cells.
Cruz-Tapias P; Robin P; Pontis J; Maestro LD; Ait-Si-Ali S
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
